A test for the detection of total antibodies (IgG) to hepatitis C virus antigens, used to screen patients for hepatitis C virus infection. The test detects recombinant antigens (c200 and NS5) and a synthetic HCV-encoded core peptide (c22). The response to the core protein is an early indicator of HCV infection.

Possible situations for the detection of HCV antibodies

• In patients who have recovered from infection (antibodies may persist for up to 8-10 years).
• In children born to mothers with hepatitis C.
• After transfusion of blood containing these antibodies.

Indications for use

• Increased ALT and AST levels
• Preparation for surgery
• Parenteral manipulations
• Preparation for pregnancy
• Unprotected sexual intercourse, frequent change of sexual partners
• Drug use by injection or intranasal route
• Undergoing hemodialysis or currently undergoing dialysis
• Receiving donated blood and its components
• Clinical signs of HCV (cirrhosis of the liver, hepatocellular carcinoma, elevated liver function tests of unknown etiology, gastrointestinal diseases, or extrahepatic manifestations of HCV)
• People living with HIV
• Persons with tattoos, piercings
• Medical or dental procedures in conditions of uncertain infection control

Patient preparation rules:

• 4 hours before the test, fasting is necessary, fatty foods are excluded
• You can drink water
• For children under 1 year of age, it is advisable to observe the maximum possible interval between feedings or donate blood immediately before the next feeding.

Lead time: 24 hours